Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TYBEE: Suprachoroidal CLS-TA with Aflibercept for Diabetic Macular Edema
NCT03126786Phase 2Completed
- Sponsor
- Clearside Biomedical
- Start
- Jul 2017
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone in diabetic macular edema (DME), sponsored by Clearside Biomedical. Started Jul 2017; status: completed.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03126786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126786.